Home › Myelodysplastic Syndromes › Vermont
Myelodysplastic Syndromes clinical trials in Vermont
3 studies for Myelodysplastic Syndromes are looking for participants at sites in Vermont.
Cities in Vermont
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- University of Vermont Medical Center, Burlington
RecruitingObservational study
Up to age 30 · All sexes · Updated Jul 16, 2026 · NCT04968834Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes
- University of Vermont, Burlington
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 3, 2026 · NCT06692894From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.